Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Anyone? How much more dilution to go? These 5 mil dumps are painful to watch.
Wow! a 1,000 share trade at .0005 drops this -15.4%. .50c!!!
Anyone want to throw $1 to bring us back to 7's?
Crapo plans landmark cannabis banking vote
09/13/2019 05:02 AM EDT
https://www.politico.com/story/2019/09/13/crapo-cannabis-banking-vote-1729925?utm_content=100896778&utm_medium=social&utm_source=facebook&hss_channel=fbp-386888798158180&fbclid=IwAR04ZpFpAeQV0o0QmOK7BDBa2iRZJP2alLR-lnL9x7Z80oRW4d19c9UvJgE
Yes, and I've been keeping an eye on L2. That support at 5 looks promising for now though.
Need some of those 5's to move up and take out those 7's. Could be slowly coming back to life....slowly. That 10 mil bid alone can wipe out those 7's and we'd still have 14M on the bid at 5.
Vireo Health Reports Q2 Revenue of $7.2 Million
August 29, 2019 at 7:35 am
https://www.newcannabisventures.com/vireo-health-reports-q2-revenue-of-7-2-million/
Earnings Presentation Download Link...
https://s23.q4cdn.com/291493418/files/doc_financials/2019/q2/2Q19-Earnings-Slides_FINAL.pdf
Vireo Health Announces Second Quarter 2019 Financial Results
MINNEAPOLIS, Aug. 29, 2019 /PRNewswire/
https://www.prnewswire.com/news-releases/vireo-health-announces-second-quarter-2019-financial-results-300909012.html
"Total revenue for Q2 2019 was $7.2 million, up 70 percent from $4.2 million in Q2 2018"
Nice and welcome! Hopefully things start to turn around here. Earnings and conference call tomorrow, so we'll see if they have anything up their sleeve. They are growing and continually moving in the right direction. There's been a bunch of positive PR's put out in the last 6 months and I believe VREOF will be huge. IMO GLTA VREOF
Conference call information...
Thursday, August 29, 2019 8AM(EST)
The conference call may be accessed by dialing 866-211-3165 (Toll-Free) or 647-689-6580 (International) and entering conference ID 4049456.
https://investors.vireohealth.com/events-and-presentations/default.aspx.
In honor of your username, Vireo is using it for their green line :)
Their PA website shows the actual strains being used to make the different Red / Yellow / Green / Blue product lines.
Red = Jack Herer
Yellow = Granddaddy Purps
Green = OG Kush
Blue = Tangie
https://vireohealth.com/pa/
Yes, me too, but it's Thursday before market opens, not tomorrow.
MINNEAPOLIS, Aug. 21, 2019 /PRNewswire/ -- Vireo Health International, Inc. ("Vireo" or the "Company") (CNSX: VREO; OTCQX: VREOF), a leading science-focused, multi-state cannabis company, today announced that it will report financial results for its second quarter ended June 30, 2019 on Thursday, August 29, 2019 before the market opens
https://finance.yahoo.com/news/vireo-health-report-second-quarter-122500557.html
Oversold and hopefully ready to reverse course soon...
August 27, 2019
"Vireo Health International Inc (VREO.CN)’s Stochastic Momentum Index is diving lower and has passed the key level of -40, indicating possible oversold territory. The SMI indicator was developed by William Blau ad presented in Technical Analysis of Stocks & Commodities magazine in 1993, ten years after the original stochastic was invented. The oscillator fluctuates between -100 and 100, and as such the indicator can be readily used to identify overbought and oversold levels. Readings above +40 occur when the market is trading near the top of its recent price range. Readings below -40 occur when the market is trading near the bottom of its recent price range."
"Presently, Vireo Health International Inc (VREO.CN) has a 14-day Commodity Channel Index (CCI) of -144.30. The CCI technical indicator can be used to help determine if a stock is overbought or oversold. CCI may also be used to help discover divergences that could possibly signal reversal moves. A CCI closer to +100 may provide an overbought signal, and a CCI near -100 may offer an oversold signal."
https://wellstonjournal.com/2019/08/27/vireo-health-international-inc-vreo-cn-stochastic-mi-reading-touches-key-levels/
An Integrative Doctor and his story with cannabis patients: Dr. Stephen Dahmer
https://www.medpotcast.com/podcast/episode-19-an-integrative-doctor-and-his-story-with-cannabis-patients-dr-stephen-dahmer/
- Dr. Dahmer’s story
- Integrative Medicine and Dr. Probiotic
- How Vireo got started
- Every patient should know what’s in their product 10:15
- Worst cannabis moment- I can’t afford it
- Does cannabis interact with your prescription meds?
- New Vireo rosin product
- Why research opportunities suck in the USA
- What’s the best ratio for chronic pain?
- THC for Sleep
- Links mentioned in the show:
How Doctor’s Die
Vireo Starter Packs
Vireo Website
Vireo helping Army veterans.
Medical marijuana industry rewarding manufacturing workers who lost prospects when companies left
Posted: 10:05 AM, Aug 26, 2019 Updated: 10:30 AM, Aug 26, 2019
https://www.news5cleveland.com/news/local-news/medical-marijuana/medical-marijuana-industry-rewarding-manufacturing-workers-who-lost-prospects-when-companies-left
Trying to make sure all important PR's are on this board. Hopefully one day we can sticky a post with all important information for easy access for new investors. GLTA VREOF
Vireo Health Affiliate Given Green Light to Operate Medical Cannabis Processing Facility in Ohio
https://www.prnewswire.com/news-releases/vireo-health-affiliate-given-green-light-to-operate-medical-cannabis-processing-facility-in-ohio-300902399.html
MINNEAPOLIS, Aug. 15, 2019 /PRNewswire/ -- Vireo Health International, Inc. ("Vireo" or the "Company") (CNSX: VREO,OTCQX: VREOF), a leading physician-led, science-focused multi-state cannabis company, today announced that the Company's affiliate, Ohio Medical Solutions ("OMS"), was granted a Certificate of Operation by the Ohio Department of Commerce. OMS, which will begin operating immediately, was previously awarded a provisional processing license.
OMS is now permitted to purchase plant material from licensed cultivators, manufacture a wide variety of Vireo-branded pharmaceutical-grade cannabis products, and wholesale these products to third-party dispensaries throughout the state of Ohio.
"We are delighted that Ohio Medical Solutions will begin manufacturing Vireo products for the benefit of Ohio patients," said Chief Executive Officer, Kyle Kingsley, M.D. "The City of Akron has been great to us and as our business grows, we look forward to continuing to create new jobs and make a positive impact on the local economy."
Located in a former factory building that had fallen into disuse and disrepair, the Company's 11,500 square-foot facility, in Akron, Ohio has been transformed, through a multi-million-dollar investment, into a state-of-the-art pharmaceutical manufacturing facility. The renovated facility features new building systems, a new roof, complete interior redesign, and the installation of a best-in-class security system and fence.
"I am honored to serve as General Manager and lead this facility," said Marie Walchalk, OMS General Manager. "As a life-long Ohioan I have personally witnessed too many manufacturing jobs leave our State and it's great to be part of an industry adding new good-paying local jobs."
Ohio's Medical Marijuana Bill (HB 523) was signed into law on June 8, 2016 by Governor Kasich. The State's medical marijuana program is rapidly expanding. Sales of medical marijuana officially began on January 16, 2019. There are now 527 certified physicians and 25 active dispensaries serving the State's 53,082 registered patients and almost 4,000 registered caregivers.
About Vireo Health International, Inc.
Vireo Health International, Inc.'s mission is to build the cannabis company of the future by bringing the best of medicine, engineering and science to the cannabis industry. Vireo's physician-led team of more than 300 employees provides best-in-class cannabis products and customer experience. Vireo cultivates cannabis in environmentally friendly greenhouses, manufactures pharmaceutical-grade cannabis extracts, and sells its products at both company-owned and third-party dispensaries. The Company currently is licensed in eleven markets including Arizona, Maryland, Massachusetts, Minnesota, New Mexico, New York, Nevada, Ohio, Pennsylvania, Puerto Rico, and Rhode Island. For more information about the company, please visit www.vireohealth.com.
Another one from last month worth posting.
Vireo Health Announces Inclusion in Horizons Marijuana Index ETFs
https://www.prnewswire.com/news-releases/vireo-health-announces-inclusion-in-horizons-marijuana-index-etfs-300876102.html
MINNEAPOLIS, June 27, 2019 /PRNewswire/ -- Vireo Health International, Inc. ("Vireo" or the "Company") (CSE: VREO;OTCQX: VREOF), a leading science-focused, multi-state cannabis company, today announced that its shares have been included in the Horizons US Marijuana Index ETF (HMUS) and the Horizons Emerging Marijuana Growers Index ETF (HMJR).
The Horizons US Marijuana Index (HMUS) was the first of its kind and seeks to track the price movements of a portfolio of North American publicly listed companies with significant business activities in the United States marijuana or hemp industries. Stocks must meet certain requirements to be included in this ETF. A company must be listed on an US or Canadian exchange, represent significant exposure in the hemp and marijuana industries, have a market capitalization greater than CAD$75M, a stock price greater than CAD$0.25, and have a 30 day average daily trading volume of greater than CAD$100,000. Stocks in this ETF are rebalanced quarterly so that no single stock holds more than 10.0 percent of the weight in the index.
The Horizons Emerging Marijuana Growers Index (HMJR) is designed to provide exposure to the performance of a basket of primarily North American publicly listed small-capitalization companies primarily involved in the cultivation, production and/or distribution of marijuana. Stocks must meet certain requirements to be included in this ETF. A company must be listed on a regulated stock exchange in a developed market; be a cultivator, producer, and/or distributor of marijuana or cannabis; and have a market capitalization greater than CAD$50M. Stocks in this ETF are rebalanced quarterly so that no single stock holds more than eight percent of the weight in the index.
About Vireo Health International, Inc.
Vireo Health International, Inc.'s mission is to build the cannabis company of the future by bringing the best of medicine, engineering and science to the cannabis industry. Vireo's physician-led team of more than 350 employees provides best-in-class cannabis products and customer experience. Vireo cultivates cannabis in environmentally-friendly greenhouses, manufactures pharmaceutical-grade cannabis extracts, and sells its products at both company-owned and third-party dispensaries. The Company is currently licensed in eleven states and territories: Arizona, Maryland, Massachusetts, Minnesota, Nevada, New Mexico, New York, Ohio, Pennsylvania, Puerto Rico and Rhode Island. For more information about the company, please visit www.vireohealth.com.
Contact Information
Investor Inquiries
Sam Gibbons
Vice President, Investor Relations
samgibbons@vireohealth.com
(612) 314-8995
Media Inquiries
Albe Zakes
Vice President, Corporate Communications
albezakes@vireohealth.com
(267) 221-4800
SOURCE Vireo Health International, Inc.
Related Links
https://www.vireohealth.com
A few weeks old, but worth posting. VREOF went from gray (then pink?) status to OCTQX. The final jump to either NYSE or NASDAQ wouldn't be a long shot and I can see it happening, just not sure on the time frame or requirements.
OTC Markets Group Welcomes Vireo Health International Inc. to OTCQX
https://www.prnewswire.com/news-releases/otc-markets-group-welcomes-vireo-health-international-inc-to-otcqx-300895373.html
NEW YORK, Aug. 2, 2019 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced Vireo Health International Inc. (CSE: VREO;OTCQX: VREOF), a leading cannabis company whose mission is to bring the best of medicine, engineering and science to the cannabis industry, has qualified to trade on the OTCQX® Best Market.
Vireo Health International begins trading today on OTCQX under the symbol "VREOF." U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com.
"We are pleased to welcome Vireo Health International to the OTCQX Best Market," said Jason Paltrowitz, EVP of Corporate Services at OTC Markets Group. "Along with their recent listing on the Canadian Securities Exchange in March and subsequent M&A transactions, trading on the OTCQX Market in the U.S. will enable Vireo Health to build stronger visibility and awareness across North America and provide investors with transparent trading. We look forward to supporting the company in the U.S. public market."
MCAP LLC acted as Vireo Health International's OTCQX sponsor.
About Vireo Health International Inc.
Vireo's mission is to build the cannabis company of the future by bringing the best of medicine, engineering and science to the cannabis industry. The company's physician-led team of more than 300 employees provides best-in-class cannabis products and customer experience. Vireo cultivates cannabis in environmentally-friendly greenhouses, manufactures pharmaceutical-grade cannabis extracts, and sells its products at both company-owned and third-party dispensaries. The company is currently licensed in ten states including Arizona, Maryland, Massachusetts, Minnesota, Nevada, New Mexico, New York, Ohio, Pennsylvania, and Rhode Island.
Product List
https://vireohealth.com/ny/products/
Yep, long overdue for a change in direction and it's frustrating. So many positives in the works here. Hoping the financials next Thursday AM help light a fire under this. They are definitely growing and making big moves. This must be the most under valued MSO (multi-State operator - 10 States) in the industry. I'm also a Vireo patient in NY, and have 1st hand experience with them. From a patient standpoint, they are organized, reliable and provide great products. They've also been updating their website with new products. IMO GLTA VREO $$$
"The Company will hold a conference call and webcast to discuss its business and financial results that same day at 8:30 a.m. Eastern Time (7:30 a.m. Central Time). A live audio webcast of the call will be available in the Events & Presentations section of Vireo's website at https://investors.vireohealth.com/events-and-presentations/default.aspx. The conference call may also be accessed by dialing 866-211-3165 (Toll-Free) or 647-689-6580 (International) and entering conference ID 4049456. A webcast replay will be available for one year on Vireo's website."
For anyone that missed the previous earnings report in May...
https://www.prnewswire.com/news-releases/vireo-health-announces-first-quarter-2019-financial-results-300859707.html
MINNEAPOLIS, May 31, 2019 /PRNewswire/ -- Vireo Health International, Inc. ("Vireo" or the "Company") (CSE: VREO), a leading science-focused, multi-state cannabis company, today reported financial results for its first quarter ended March 31, 2019. All currency figures referenced in this release reflect U.S. dollar amounts, unless otherwise noted.
"We continued to experience strong revenue growth during the first quarter, with increasing patient counts in Minnesota and New York and contributions from wholesale revenue streams in Maryland and Pennsylvania during the quarter," said Founder & CEO, Kyle Kingsley, M.D. "It was also a very successful quarter from an execution standpoint, as we completed several strategic acquisitions and began construction on many development projects that will help us meet the growing demand for our products across our operating footprint."
"Following the successful completion of our RTO transaction in March and subsequent acquisition activities, Vireo's future has never looked brighter. We have a world-class team of professionals leading our expansion strategies, and we believe that our focus on bringing the best of medicine, science, and engineering to the cannabis industry will create compelling long-term value for all of our stakeholders."
Business Highlights
During the first four months of 2019, the Company acquired various cannabis licenses and real estate in the states of Arizona, Massachusetts, Nevada, New Mexico, and Rhode Island. These acquisition activities expanded Vireo's licensed footprint to 10 states nationwide.
The Company generated operating revenue in six states during the first quarter of 2019: Arizona, Maryland, Minnesota, New Mexico, New York and Pennsylvania. Total revenue for Q1 2019 increased 57 percent year-over-year to $5.8 million versus Q1 2018. Pro-forma revenue for the quarter, including total first quarter revenue from recently completed acquisitions in Arizona and New Mexico, was approximately $7.0 million.
Net loss for Q1 2019 was approximately $3.4 million, as compared to $2.0 million in the prior year quarter. Adjusted net income, as described in accompanying disclosures and footnotes, was $2.0 million in Q1 2019, as compared to a loss of $0.9 million in the prior year quarter.
Q1 2019 EBITDA and Adjusted EBITDA, as described in accompanying disclosures and footnotes, was $172,506 and $3.8 million respectively, as compared to a loss of $856,803 and a gain of $273,521, respectively, during the prior year quarter.
On March 20, 2019, Vireo commenced trading on the Canadian Securities Exchange under ticker symbol "VREO" following the successful completion of the Company's reverse takeover ("RTO") of Darien Business Development Corp. In conjunction with the RTO, Vireo raised approximately $51.4 million in proceeds through a brokered and non-brokered private placement.
First Quarter 2019 Financial Summary
Total revenue for Q1 2019 was $5.8 million, up 57 percent from $3.7 million in Q1 2018. Revenue growth was driven by a combined increase of $1.3 million in the states of Minnesota and New York, as well as wholesale revenue generation in the states of Maryland and Pennsylvania.
Retail revenue was approximately $5.2 million in Q1 2019, an increase of approximately 40 percent compared to $3.7 million in Q1 2018. Wholesale revenue was $610,881 in Q1 2019 and reflected revenue contributions from wholesale markets in Maryland and Pennsylvania. The Company did not operate any wholesale revenue channels during the prior year quarter.
Gross profit before fair value adjustments was $2.1 million, or 37 percent of revenue, as compared to $1.9 million or 50 percent, in the same period last year. Gross profit after fair value adjustments and net gains on growth of biological assets was $7.2 million or 124 percent of revenue, as compared to 2.3 million and 64 percent in the same period last year. The year-over-over increase in gross margin after fair value adjustments of biological assets was attributable to significant improvements in cultivation yields.
Total operating expenses were $3.7 million, as compared to $3.3 million in the same period last year. Total operating expenses include selling, general and administrative ("SG&A") expenses, which totaled $1.4 million, as compared to $735,032 last year. The increase in SG&A expenses was primarily attributable to increased salaries and wages, share-based compensation, professional fees, and general and administrative expenses to support the Company's growing business, as well as start-up expenses related to buildout and pre-revenue operations in the states of Maryland and Ohio.
Total other expense was $4.6 million during Q1 2019. These non-operating expenses primarily reflect listing expenses related to the Company's recent RTO and subsequent listing on the Canadian Securities Exchange, as well as interest expenses associated with recent sale-and-leaseback transactions of certain cultivation facilities.
Net loss attributable to Vireo in Q1 2019 was $3.4 million, as compared to a net loss of approximately $2.0 million in Q1 2018. Adjusted net income for Q1 2019 was$219,041, as compared to a loss of approximately $0.9 million in the prior year quarter.
Q1 2019 EBITDA was $172,506, as compared to a loss of $856,803 in Q1 2018. Excluding listing expense and share-based compensation expenses, Vireo generated Adjusted EBITDA of $3.8 million in Q1 2019, compared to $273,521 in Q1 2018. Please refer to the Supplemental Information and Reconciliation of Non-IFRS Financial Measures at the end of this press release for additional information.
Subsequent Events
On May 29, 2019, the Company announced the hiring of Harris Rabin as Chief Marketing Officer. Mr. Rabin will be responsible for overseeing Vireo's brand marketing, e-commerce, retail, and other sales initiatives. Mr. Rabin is an accomplished marketing leader and joins Vireo with two decades of experience, including senior leadership roles in the consumer healthcare and beverage alcohol industries. He most recently served as Global Vice President of Marketing at Anheuser-Busch InBev (ABInBev), where he oversaw a multi-billion-dollar global portfolio of core beer brands.
On May 30, 2019, the state of Minnesota enacted new legislation amending the state's medical cannabis program. These measures were passed as part of a health and human services bill, and will allow for the existing licensed operators in the state to double the number of dispensaries, as well as to write off some business expenses and buy hemp from local farmers. These changes will result in Vireo Health increasing its number of dispensaries in the state from four to eight, and increases Vireo's total number of dispensary licenses to 32 as of the date of this announcement.
Balance Sheet and Liquidity
As of March 31, 2019, total assets were $146.4 million, including cash on hand of $40.4 million. Total long-term liabilities were $37.1 million as of March 31, 2019, with $1.0 million of debt currently due within 12 months.
As of March 31, 2019, there were 21,641,441 equity shares issued and outstanding, and 109,360,128 shares outstanding on an as converted, fully diluted basis.
2019 Outlook
During fiscal year 2019, Vireo continues to expect to conduct the following development activities:
- Launch Green Goods™ dispensaries in Pennsylvania and expand existing retail footprint in New Mexico
- Increase cultivation and processing capacity in Arizona, Minnesota, New Mexico and New York
- Begin build-out of new facilities in Massachusetts, Nevada, Puerto Rico, and Rhode Island
- Roll out new cannabis brands and innovative products in multiple state-based markets
- Wholesale Vireo-branded products to third-party dispensaries in Ohio
- Plant industrial hemp crops for IP development in Minnesota and New York
- The Company currently expects to exit the year with at least 20 operational dispensaries across its nationwide footprint.
- Dr. Kingsley commented, "Fiscal year 2019 will be a pivotal year of growth for Vireo Health, as we anticipate the addition of at least six new revenue generating states during the year. The rollout of our Green Goods™ dispensaries in Pennsylvania is on schedule, and we now anticipate that we'll exit the year with at least 20 operational dispensaries across our nationwide footprint. We are continuing to pursue additional organic and acquisitive growth opportunities, as well as the development of monetizable intellectual property, and we also believe improving regulatory environments in many of our state jurisdictions could present additional opportunities for growth over the near- to medium-term future."
Conference Call and Webcast Information
Vireo Health management will host a conference call with research analysts on Friday, May 31, 2019 at 8:30 a.m. ET to discuss its financial results for its first quarter ended March 31, 2019. The conference call may be accessed by dialing 866-211-3165 (Toll-Free) or 647-689-6580 (International) and entering conference ID 8184214.
A live audio webcast of this event will also be available in the Events & Presentations section of the Company's Investor Relations website at https://investors.vireohealth.com/events-and-presentations/default.aspx and will be archived for one year.
Additional Information
Additional information relating to the Company's first quarter and 2019 results is available on SEDAR at www.sedar.com. Vireo Health refers to certain non-IFRS financial measures such as adjusted net income, Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA) and adjusted EBITDA (defined as earnings before interest, taxes, depreciation, amortization, less certain non-cash equity compensation expense, one-time transaction fees, and other non-cash items. These measures do not have any standardized meaning prescribed by IFRS and may not be comparable to similar measures presented by other issuers. Please see the Supplemental Information and Reconciliation of Non-IFRS Financial Measures at the end of this news release for more detailed information regarding non-IFRS financial measures.
About Vireo Health International, Inc.
Vireo's mission is to build the cannabis company of the future by bringing the best of medicine, engineering and science to the cannabis industry. The Company's physician-led team of more than 300 employees provides best-in-class cannabis products and customer experience. Vireo cultivates cannabis in environmentally-friendly greenhouses, manufactures pharmaceutical-grade cannabis extracts, and sells its products at both company-owned and third-party dispensaries. The Company is currently licensed in ten states including Arizona, Maryland, Massachusetts, Minnesota, Nevada, New Mexico, New York, Ohio, Pennsylvania, and Rhode Island. For more information about the company, please visit www.vireohealth.com.
Undervalued, oversold and earnings will be very intereting to see next week. 300 employees...multi-state operator, a moster in the making. Last few months have been rough here, but I have a feeling all will change soon. Hopefully earnings will turn a few heads. GLTA $$$VREOF$$$
Vireo Health Affiliate Given Green Light to Operate Medical Cannabis Processing Facility in Ohio
https://www.prnewswire.com/news-releases/vireo-health-affiliate-given-green-light-to-operate-medical-cannabis-processing-facility-in-ohio-300902399.html
MINNEAPOLIS, Aug. 15, 2019 /PRNewswire/ -- Vireo Health International, Inc. ("Vireo" or the "Company") (CNSX: VREO,OTCQX: VREOF), a leading physician-led, science-focused multi-state cannabis company, today announced that the Company's affiliate, Ohio Medical Solutions ("OMS"), was granted a Certificate of Operation by the Ohio Department of Commerce. OMS, which will begin operating immediately, was previously awarded a provisional processing license.
Vireo Health to Report Second Quarter 2019 Results on August 29, 2019
https://finance.yahoo.com/news/vireo-health-report-second-quarter-122500557.html
"MINNEAPOLIS, Aug. 21, 2019 /PRNewswire/ -- Vireo Health International, Inc. ("Vireo" or the "Company") (CNSX: VREO; OTCQX: VREOF), a leading science-focused, multi-state cannabis company, today announced that it will report financial results for its second quarter ended June 30, 2019 on Thursday, August 29, 2019 before the market opens"
What a tease yesterday was...almost jumped back in, then back to reality today. Just shows how fast this can run if real news hits. Though, not sure I have the stomach or patience to watch and wait anymore. Already made a few donations to help with their dilution and to treat my FOMO. Contemplating taking a chunk out of those 6's... BLPG save us all! :)
Lots of good stuff in the works and very transparent here...
- Finalized acquisition of a 265-acre Ranch in Paso Robles, California via our subsidiary to establish the world’s first Estate Grown Weedery.
- Received cultivation/nursery and distribution permits for nursery in Coachella, California.
- Received cultivation/nursery Minor Use Permit for its nursery in Paso Robles, California.
- Received Annual CA State distribution license from the California Bureau of Cannabis Control.
- Began operation of statewide distribution division GHC Ventures for distribution of cannabis products throughout California.
Applied for Minor Use Permit for outdoor cultivation on Estrella Ranch.
-Commenced the vetting process and begun negotiations with several potential third-party operators for Estrella Ranch.
-Executed “7X Pure” Private Label Agreement with botanical company with first product release imminent.
-Engaged research teams with highly recognized athletes and published experts to commence with leading-edge research to explore the application of cannabinoid products for human and equine applications.
-Advancing plans for expansion into the sports and cosmetics markets for CBD or THC infused products.
-Continuing to explore potential acquisition targets and strategic alliances.
-Continued preparation for up-listing to OTCQB through financial audits and OTC filings.
Yep, looks like this company cares about it's shareholders! I like it, and the 2,000% increase of revenue too! Sounds like the future is bright with this one ;)
Just in case you missed this part of the PR this morning...LVVV $$$GLTA$$$
"did not issue any new shares during the second quarter of 2019, keeping down dilution for our existing shareholders."
http://www.globenewswire.com/news-release/2019/08/22/1905494/0/en/LiveWire-Ergogenics-Inc-Reports-Second-Quarter-2019-Financial-Results.html
Vireo Health Files Patent for Multichannel Vaporizer
https://vireohealth.com/?p=10804&utm_content=97238602&utm_medium=social&utm_source=facebook&hss_channel=fbp-1055397751155005&fbclid=IwAR1Qw72uq5WGCAx0JGqbNhMlE994LDOgJ7jdj22VSqWKyu7-Adrd9Epokz0
"MINNEAPOLIS – July 25, 2019 – Vireo Health International, Inc. (“Vireo” or the “Company”) (CNSX: VREO), a leading physician-led, science-focused multi-state cannabis company, today announced that the Company filed a patent application with United States Patent and Trademark Office (“USPTO”) for a multichannel vaporizer designed to hold at least two vaporizer cartridges. The device will allow a user to adjust the mixture of vapor coming from each cartridge using a simple interface.
“Vireo Health is committed to helping consumers find their ‘cannabis sweet spot’ whether they are a connoisseur or a first-time user,” said Founder and CEO Kyle Kingsley, M.D. “When developed,
in addition to potential medical benefits, we expect that the multichannel vaporizer will allow consumers to control and adjust their own experience or even create their own custom blends of different strains, terpene profiles, and flavors.”
Currently, if a consumer or patient wants to use more than one vaporizer formulation, he or she needs to purchase a separate vaporizer cartridge for each formulation. For example, if a user wanted the full spectrum of THC to CBD ratios that Vireo offers, the patient would have to purchase five different cartridges. The user would also need to purchase a separate battery for each cartridge or change out the cartridges every time he or she wanted to use a different formulation.
The multichannel vaporizer will be a single device that will allow a user to carefully change and control the desired effect for every inhalation. In one application¬¬ of the invention, the vaporizer would house a separate THC cartridge and CBD cartridge, thus enabling the user to adjust the THC to CBD ratio of the vapor to his or her preference in real time."
Vireo Health Launches New York's First Same-Day Marijuana Delivery Service
https://www.prnewswire.com/news-releases/vireo-health-launches-new-yorks-first-same-day-marijuana-delivery-service-300885679.html
NEW YORK, July 16, 2019 /PRNewswire/ -- Vireo Health of New York ("Vireo" or the "Company"), a subsidiary of Vireo Health International (CSE: VREO), a leading physician-led, science-focused multi-state cannabis company, today announced that patients living in the New York City metro area, Westchester County, and Nassau County now have access to free, same-day marijuana delivery.
Launched in April 2017, Vireo's medical marijuana home delivery service has rapidly expanded. Since its inception, the Company has made more than 25,000 home deliveries to patients. With over 1,000 Google reviews with an average 4.9 out of 5 star rating, it is now the first company in New York to offer a free same-day delivery option.
"Our same-day home delivery service is designed to match the convenience that New Yorkers have become accustomed to in the era of Amazon, Uber and Seamless," said Founder and Chief Executive Officer, Kyle Kingsley, M.D. "The growing popularity of our home delivery service has allowed us to achieve the economies of scale necessary to offer same-day delivery throughout the Greater New York City area."
Vireo's home delivery service was designed by a team of security experts, pharmacists, and health-care providers. "As a physician-led company, our goal is to provide safe and effective products in a trusted and supportive environment, and nothing is safer than one's own home. We want to ensure that all our patients do not feel stigmatized and can receive the highest quality service and products with the convenience they deserve," said Stephen Dahmer, M.D., Chief Medical Officer of Vireo Health.
Patients who place orders by 12:00 p.m. EDT will be eligible to receive free same-day delivery. Payment for deliveries can be made using CanPay, a cannabis debit payment app available on iPhone and Android devices. More information is available online at www.vireohealth.com/ny/delivery.
About Vireo Health International, Inc.
Vireo Health International, Inc.'s mission is to build the cannabis company of the future by bringing the best of medicine, engineering and science to the cannabis industry. Vireo's physician-led team of more than 350 employees provides best-in-class cannabis products and customer experience. Vireo cultivates cannabis in environmentally friendly greenhouses, manufactures pharmaceutical-grade cannabis extracts, and sells its products at both company-owned and third-party dispensaries. The Company currently is licensed in eleven markets including Arizona, Maryland, Massachusetts, Minnesota, New Mexico, New York, Ohio, Pennsylvania, Puerto Rico, and Rhode Island. For more information about the company, please visit www.vireohealth.com.
Yep, it was pumped and dumped.
No, it's not up 30% SMH. Too many pumpers on here and too little facts.
Almost 3hrs later, the same 1.6M traded. No movement, NONE.
Yawn....only 1.6M traded so far today.
So much pumping going on here, but my L2 showing a different tale. Not looking very strong and nothing but small bids with little buying.
October...just when this is just about to hit .0001
Everyone wanted 8's, now there's an unlimited supply.